Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Griemsmann

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Deutsches Arzteblatt International|August 1, 2022
Metamizole-Associated Risks in Decompensated Hepatic CirrhosisBenjamin Schulte, Tammo L Tergast, Marie Griemsmann, et al.
Hepatology (Baltimore, Md.)|January 16, 2025
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.
Hepatology (Baltimore, Md.)|July 30, 2024
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.
Journal of Hepatology|March 23, 2024
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.
Journal of Hepatology|January 24, 2026
Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosisBenedikt Silvester Hofer, Marta Tonon, Laura Buttler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Incidence and Clinical Significance of Recompensation After HCV CureGeorg Semmler, Sabela Lens, Álvaro Hidalgo, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Deutsches Arzteblatt International|August 1, 2022
Metamizole-Associated Risks in Decompensated Hepatic CirrhosisBenjamin Schulte, Tammo L Tergast, Marie Griemsmann, et al.
Hepatology (Baltimore, Md.)|January 16, 2025
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.
Hepatology (Baltimore, Md.)|July 30, 2024
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.
Journal of Hepatology|March 23, 2024
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.
Journal of Hepatology|January 24, 2026
Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosisBenedikt Silvester Hofer, Marta Tonon, Laura Buttler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Incidence and Clinical Significance of Recompensation After HCV CureGeorg Semmler, Sabela Lens, Álvaro Hidalgo, et al.
Pageof 2